跳至主要内容
临床试验/ACTRN12614000070639
ACTRN12614000070639招募中3 期

A randomised controlled trial of low versus normal dialysate sodium, to assess the effect on myocardial micro-injury in patients on home and self-care haemodialysis

The Centre for Clinical Research and effective practice (CCRep), registered with the New Zealand Charities Commission (ref# CC21537)0 个研究点目标入组 118 人开始时间: 2014年1月21日最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
118

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Incident or prevalent patients treated with maintenance home or self-care haemodialysis for end-stage kidney failure
  • 2. Aged 18 years or older
  • 3. Suitable for both low and standard dialysate [Na+] in the view of the treating physician
  • 4. The person is willing to participate and has signed the Participant Information and Consent Form
  • 5. Pre-dialysis plasma [Na+] > or = 135mM
  • 6. The treating nephrologist agrees to the person’s participation in the SOLID trial

排除标准

  • 1. Haemodialysis treatments at a frequency of greater than 3.5 times per week
  • 2. Treatment with maintenance haemodiafiltration
  • 3. Life expectancy of less than 12 months
  • 4. Scheduled for live donor kidney transplantation within 12 months of entry to the study
  • 5. Considered by the treating nephrologist to have concomitant illnesses or conditions that limit or contraindicate study procedures and followup (e.g. frequent intra-dialytic hypotension requiring fluid resuscitation)
  • 6. Considered by the treating nephrologist to have a high chance of non-adherence to study treatments and non-attendance for procedures and follow-up
  • 7. Current enrolment in clinical studies involving antihypertensive medications, changes in HD operating parameters, or any other intervention that is likely to confound the outcome of this trial
  • 8. Documented obvious infiltrative cardiomyopathies (amyloid, glycogen storage disease), hereditary cardiomyopathies (hypertrophic cardiomyopathy), or moderate to severe aortic valve disease (aortic stenosis, regurgitation)

研究者

发起方
The Centre for Clinical Research and effective practice (CCRep), registered with the New Zealand Charities Commission (ref# CC21537)

相似试验